{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:45:33Z","timestamp":1761126333450},"reference-count":34,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2001,12,21]],"date-time":"2001-12-21T00:00:00Z","timestamp":1008892800000},"content-version":"vor","delay-in-days":264,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver"],"published-print":{"date-parts":[[2001,4]]},"abstract":"<jats:p><jats:bold>Abstract:<\/jats:bold>  <jats:italic>Background\/Aims:<\/jats:italic> Insulin\u2010like growth factor\u2010I (IGF\u2010I) levels are low in patients with chronic liver disease (CLD) and have been found to correlate with measurements of bone mineral density (BMD) in men with viral cirrhosis. The aim of this study was to investigate the relationship between circulating IGF\u2010I levels and BMD in patients with CLD of other causes. <jats:italic>Methods:<\/jats:italic> Fifty\u2010eight patients with CLD were included. Age\u2010 and sex\u2010matched normal individuals served as controls. Serum levels of IGF\u2010I and IGF\u2010II and their binding proteins (IGFBP\u20101\u20133) were measured by radioimmunoassay. BMD was measured by dual energy X\u2010ray absorptiometry. <jats:italic>Results:<\/jats:italic> IGF\u2010I levels were 57\u00b133 and 136\u00b148 ng\/ml; <jats:italic>p<\/jats:italic>&lt;0.0001 in patients and controls, respectively. IGF\u2010II and IGFBP\u20103 levels were lower (<jats:italic>p<\/jats:italic>&lt;0.0001) and IGFBP\u20101 and IGFBP\u20102 levels were higher in patients compared with controls (<jats:italic>p<\/jats:italic>&lt;0.0005 and <jats:italic>p<\/jats:italic>&lt;0.0001, respectively). All growth factors, except for IGFBP\u20102, correlated with parameters of liver function. In a multiple regression analysis, adjusting for age, no correlation was found between IGF\u2010I, IGF\u2010II, IGFBP\u20101\u20133 and BMD in either patients or controls. <jats:italic>Conclusion:<\/jats:italic> Patients with CLD have low levels of IGF\u2010I, IGF\u2010II and IGFBP\u20103 that correlate with liver function. No relationship was found between low levels of growth factors and BMD.<\/jats:p>","DOI":"10.1034\/j.1600-0676.2001.021002123.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T10:24:08Z","timestamp":1047464648000},"page":"123-128","source":"Crossref","is-referenced-by-count":23,"title":["Circulating levels of insulin\u2010like growth factors and their binding proteins in patients with chronic liver disease: lack of correlation with bone mineral density"],"prefix":"10.1111","volume":"21","author":[{"given":"Sif","family":"Ormarsd\u00f3ttir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6sten","family":"Ljunggren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Mallmin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Olofsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner F.","family":"Blum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"L\u00f6\u00f6f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,21]]},"reference":[{"key":"e_1_2_5_2_2","volume-title":"Diseases of the liver and biliary system,","author":"Sherlock S","year":"1993"},{"key":"e_1_2_5_3_2","first-page":"1462","article-title":"Bone disease in liver transplant recipients: incidence, timing and risk factors.","volume":"23","author":"Porayko M K","year":"1991","journal-title":"Transplant Proc"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-103-6-855"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1220611"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-122-1-254"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-219-44310"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1992.tb00550.x"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1380627"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1998.13.8.1343"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000171362"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280315"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(98)80211-0"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.9.2795"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1997.12.8.1272"},{"key":"e_1_2_5_16_2","first-page":"680","article-title":"Growth hormone, insulinlike growth factor\u2010I1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease.","volume":"21","author":"Donaghy A","year":"1996","journal-title":"Hepatology"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800600817"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002239900452"},{"key":"e_1_2_5_19_2","volume-title":"Manual of dietetic practice,","author":"Briony T","year":"1994"},{"key":"e_1_2_5_20_2","first-page":"11","article-title":"Radioimmunoassays for IGFs and IGFBPs.","volume":"4","author":"Blum W F","year":"1994","journal-title":"Growth Regul"},{"key":"e_1_2_5_21_2","first-page":"427","article-title":"Insulin\u2010like growth factors and their binding proteins in plasma and milk after growth hormone\u2010stimulated galactopoesis in normally lactating women.","volume":"129","author":"Breier B H","year":"1993","journal-title":"Acta Endocrinol"},{"key":"e_1_2_5_22_2","first-page":"100","article-title":"Clinical studies of IGFBP\u20102 by radioimmunoassay.","volume":"3","author":"Blum W F","year":"1993","journal-title":"Growth Regul"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(89)90783-X"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1211366"},{"key":"e_1_2_5_25_2","first-page":"359","article-title":"Reduced serum somatomedin activity in patients with chronic liver disease.","volume":"47","author":"Wu A","year":"1974","journal-title":"Clin Sci Mol Med"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.12.7088"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1994.tb06076.x"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.55.12.870"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.9.2799"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/s8756-3282(98)00066-0"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80167-6"},{"key":"e_1_2_5_32_2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/ajcn\/41.2.191","article-title":"Use of plasma somatomedin\u2010C\/insulin\u2010like growth factor l measurements to monitor the response to nutritional repletion in malnourished patients.","volume":"41","author":"Clemmons D R","year":"1985","journal-title":"Am J Clin Nutr"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0899-9007(96)00399-1"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510230521"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-73-4-907"}],"container-title":["Liver"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0676.2001.021002123.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0676.2001.021002123.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1600-0676.2001.021002123.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T20:08:14Z","timestamp":1697573294000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1600-0676.2001.021002123.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,4]]}},"alternative-id":["10.1034\/j.1600-0676.2001.021002123.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1600-0676.2001.021002123.x","archive":["Portico"],"relation":{},"ISSN":["0106-9543","1600-0676"],"issn-type":[{"value":"0106-9543","type":"print"},{"value":"1600-0676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,4]]}}}